LENSAR (LNSR) Projected to Post Earnings on Thursday

LENSAR (NASDAQ:LNSR) is expected to post its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect LENSAR to post earnings of ($0.10) per share and revenue of $20.30 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, February 27, 2026 at 8:30 AM ET.

LENSAR Trading Down 2.9%

NASDAQ LNSR opened at $11.32 on Thursday. The company has a market cap of $135.16 million, a price-to-earnings ratio of -2.58 and a beta of 0.69. The company has a 50 day moving average of $12.00 and a 200-day moving average of $11.88. LENSAR has a 1-year low of $8.96 and a 1-year high of $17.31.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of LENSAR in a research report on Thursday, January 22nd. Wall Street Zen upgraded shares of LENSAR to a “hold” rating in a research note on Friday, November 28th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, LENSAR presently has a consensus rating of “Reduce” and an average target price of $15.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. BNP Paribas Financial Markets grew its holdings in shares of LENSAR by 129.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,008 shares of the company’s stock valued at $25,000 after purchasing an additional 1,131 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of LENSAR by 584.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 4,674 shares of the company’s stock valued at $62,000 after acquiring an additional 3,991 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in LENSAR during the 2nd quarter worth $68,000. New York State Common Retirement Fund acquired a new position in LENSAR in the 2nd quarter worth about $105,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in LENSAR in the third quarter valued at about $125,000. Institutional investors own 40.15% of the company’s stock.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.